Descriptive and Correlational Study of Peritonitis in Haiti.

February 1, 2020 updated by: JEAN PAUL Axler, Universite d'Etat d'Haiti

Descriptive and Correlational Study of the Epidemiological, Clinical and Etiological Characteristics of Peritonitis in the Surgical Department of the State University Hospital of Haiti During the Period From January 2013 to December 2018

The primary objective:

To study the prevalence, etiology, and factors associated with the severity of peritonitis and its complications in the surgery department of the State University Hospital of Haiti.

Secondary objectives:

  • Identify epidemiological characteristics.
  • Describe the main etiologies encountered in the service
  • Measure the time required for treatment and its consequences on the evolution of peritonitis.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Generalized secondary peritonitis is one of the most common emergencies encountered in surgical departments . It is a major surgical condition with a mortality of up to 20% and classified as the third most common cause of surgical abdomens after appendicitis and intestinal obstruction . Delays in surgical management are conditions that increase mortality. While early prognostic assessment of peritonitis is essential for the objective classification of the severity of the disease, the late presentation of the majority of patients to health facilities affects this situation, further complicating effective management and promoting the occurrence of complications . It has been observed that classifying the severity of peritonitis has a major contribution to decision-making and improves management. Thus, many scoring systems have been designed and successfully used to assess the severity of acute peritonitis, including: Acute physiology and chronic health evaluation (APACHE) II score, Simplified acute physiology score (SAPS), Sepsis severity score (SSS), Ranson score, Imrite score, Mannheim peritonitis index (MPI) 6. The Mannheim Peritonitis Index (MPI) is a specific score, which is highly accurate and allows clinical parameters to be easily manipulated, allowing the individual prognosis of patients with peritonitis to be predicted . In Haiti, few studies on surgical pathologies are available. And with regard to peritonitis, only two thesis works have been listed on the subject, including one carried out at the Justinian University Hospital of Cap-Haitian on 176 patients by Dr. Jacques Julmice, who presents the main etiologies of peritonitis over a 5-year period. And the other one carried out at the Albert Schweizer Hospital by Dr. Moise Aristide, still on the etiological factors of peritonitis. These two studies are carried out outside the country's metropolitan region (the most populated region) and that they only explored the different etiologies without taking into account the time required for treatment and the gravity factors of peritonitis. Therefore, our study aims to explore the demographic, clinical and etiological factors of peritonitis in the main referral hospital in the metropolitan region of the country, as well as the time required for treatment and its relationship with the severity of the disease.

Study Type

Observational

Enrollment (Actual)

91

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ouest
      • Port-au-Prince, Ouest, Haiti, HT6140
        • Axler JEAN PAUL

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

11 years to 82 years (Child, Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

The study population is composed of all patients diagnosed, hospitalized and operated on in the peritonitis ward during the study period.

Sampling is probabilistic, simple random sampling. To estimate the sample size, we considered the peritonitis prevalence of an African study on the particularity of peritonitis in tropical environments, an environment that reflects our reality in ecological, demographic and epidemiological terms, namely 19% . The standard error rate chosen was 5%. This allows us to estimate our sample at 88 with a confidence interval of 97%. Given the possibility of finding missing files at the State University Hospital of Haïti, our sample was adjusted to 20% (standard non-response rate).

Description

Inclusion Criteria:

Patients whose peritonitis diagnosis was made and operated on in the department during the period.

Patient whose record is identified (with age, sex) with at least the clinical and etiological diagnosis identified in the operating protocol.

Exclusion Criteria:

Patients with incomplete records.

Cases of post-operative peritonitis.

Patient under 10 years of age

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Only
  • Time Perspectives: Retrospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Heart Rate
Time Frame: immediately after admission, up to 30 minutes
Heart rate number of beats/min reported in the file entry for each patients
immediately after admission, up to 30 minutes
Respiratory Rate
Time Frame: immediately after admission, up to 30 minutes
Respiratory rate number of cycle/min reported in the file of entry
immediately after admission, up to 30 minutes
Temperature
Time Frame: immediately after admission, up to 30 minutes
Temperature in celsius reported in the file of entry
immediately after admission, up to 30 minutes
Blood Pressure
Time Frame: immediately after admission, up to 30 minutes
Systolic Blood pressure in mmHg reported in the file of entry
immediately after admission, up to 30 minutes
Etiological Diagnosis
Time Frame: immediately post-surgery
final diagnosis retained in the operating protocol
immediately post-surgery
Demographic Parameters
Time Frame: during admission
Age in years described in the admission file
during admission

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Onset of Symptoms
Time Frame: immediately after admission
Days before coming at the hospital
immediately after admission
Delay in Pre-op
Time Frame: immediately post-surgery
the pre-operative time in days which describes the time between the date of the intervention and the date of admission
immediately post-surgery
Delay in Post-op
Time Frame: immediately after hospitalization
the time in days between the date of the intervention and the leaving of the patient at the hospital
immediately after hospitalization
Delay in Hospital
Time Frame: immediately after hospitalization
the time in days between the date of admission and the date of leaving the hospital
immediately after hospitalization

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Sterman Toussaint, MD, Universite d'Etat d'Haiti

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 10, 2018

Primary Completion (Actual)

March 20, 2019

Study Completion (Actual)

October 1, 2019

Study Registration Dates

First Submitted

November 23, 2019

First Submitted That Met QC Criteria

November 26, 2019

First Posted (Actual)

December 2, 2019

Study Record Updates

Last Update Posted (Actual)

February 12, 2020

Last Update Submitted That Met QC Criteria

February 1, 2020

Last Verified

February 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • 01 (Miami VAHS)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Peritonitis

Clinical Trials on Epidemiological description

Subscribe